Panel Rejects Zimmer's Dynesys Spine Stabilization Device

FDA should not approve Zimmer's Dynesys spine stabilization system as a stand-alone treatment for degenerative spine-related leg pain due to insufficient safety and efficacy data, according to the agency's Orthopedic and Rehabilitation Devices Panel

More from Archive

More from Medtech Insight